Pfizer said it might have a coronavirus vaccine for emergency use this fall. “This is a crisis right now, and a solution is desperately needed by all,” the CEO said.
Pfizer may have a coronavirus vaccine ready for emergency use in autumn, the New York pharmaceutical giant’s chief executive, Albert Bourla, said Tuesday.
Testing of the medication has begun in Germany and could start in the U.S. next week if health regulators agree to that, Bourla told The Wall Street Journal in an interview.
Results from the study may emerge as soon as May, he said. But Pfizer would still need to complete additional safety testing.
If the vaccine passes through all the testing levels, Pfizer could start distributing it on an emergency basis in the fall and perhaps gain regulators’ clearance for widespread distribution this year, Bourla said.
“This is a crisis right now, and a solution is desperately needed by all.”